Related by context. Frequent words. (Click for all words.) 72 Initiates Phase II 69 Presents Positive 68 Commences Phase 66 Receives Orphan Drug Designation 66 fibrosis IPF 65 Initiate Phase 65 Completes Enrollment 65 addressing idiopathic pulmonary 65 Meets Primary Endpoint 65 Initiates Phase 65 novel orally administered 64 Idera Pharmaceuticals 63 Phase Ib II 63 developing Zerenex TM 63 MKC# 63 Study Evaluating 63 NASDAQ CRXL 63 IMC #B 63 Panzem R 62 Crucell NV Euronext 62 CD#.# DOES NOT ENDORSE 62 JAK1 62 Sapacitabine 61 Tesetaxel 61 R bortezomib 61 Drug Candidate 61 Pivotal Phase III 61 HOW LONG WAS 61 phase IIa clinical 61 AQ4N 61 Pivotal Phase 61 Onalta 61 drug conjugate 61 Locteron ® 61 Inc. Nasdaq IMGN 61 refractory chronic lymphocytic 61 Clinical Trial Results 60 Nasdaq ENMD 60 Guanilib 60 Daclizumab 60 GVAX R 60 ALN TTR 60 IIa trial 60 BiTE R 60 ATL# [001] 60 MorphoSys AG FSE MOR 60 II Clinical Trial 60 By Arek Sarkissian 60 humanized anti 60 HCV protease inhibitor 60 multi kinase inhibitor 60 Roche SIX RO 60 liposomal formulation 60 Emisphere Technologies 60 JAK inhibitor 60 R sorafenib tablets 60 Small Molecule 60 NOXXON 60 CEQ# 59 inhaled formulation 59 Metastatic Melanoma 59 * Azixa 59 vascular disrupting agent 59 includes investigational compounds 59 Declares Dividend Quick Facts 59 BY ADRIAN NEMES 59 histone deacetylase HDAC inhibitor 59 therapeutic monoclonal antibodies 59 StromaCel Inc. 59 FDA Accepts 59 Vaccinex 59 phase IIb clinical 59 Evotec AG 59 Recombinant Human 59 Evotec AG Frankfurt 59 generation proteasome inhibitor 59 Phase III Clinical Trial 59 mediate RNAi 59 Phase Ib clinical 59 Phase Ib 59 Active Biotech AB 59 advanced carcinoid 59 Phase Ib IIa 59 proteasome inhibitor 59 BY JIM DeROGATIS 59 Guides FY# Update 59 EnVivo Pharmaceuticals 59 OSI Prosidion 59 epothilones 58 targeting CD# 58 ALN TTR# 58 YOUR LOCAL ANIMAL SHELTER 58 Promedior 58 ANYARA 58 Shigamabs ® 58 PsychoGenics 58 cutaneous T 58 Thiarabine 58 Regulatory Disclosure 58 Trophos 58 taste modulators